ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.163,52
-0,41%
S&P 500
5.464,62
-0,16%
Dow Jones
39.150,33
0,04%
Euro vs US Dollar
1,06868
-0,05%
Bitcoin
64.102,32
-0,22%
Registration Strip Icon for discussion Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. USOTC
  6. AstraZeneca Plc (PK) (AZNCF)

  7. AstraZeneca Plc (PK) (AZNCF) News

AZNCF

AstraZeneca (PK) (AZNCF)

AstraZeneca Plc (PK)
Von:
Sortieren nach:
 Showing the most relevant articles for your search:USOTC:AZNCF
DatumZeitQuelleÜberschriftSymbolFirma
18/06/202412h38Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:AZNCFAstraZeneca Plc (PK)
17/06/202412h21Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:AZNCFAstraZeneca Plc (PK)
16/05/202412h41Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:AZNCFAstraZeneca Plc (PK)
15/05/202416h09Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:AZNCFAstraZeneca Plc (PK)
07/05/202413h31Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:AZNCFAstraZeneca Plc (PK)
07/03/202412h34Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:AZNCFAstraZeneca Plc (PK)
07/03/202412h30Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:AZNCFAstraZeneca Plc (PK)
06/03/202416h11Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:AZNCFAstraZeneca Plc (PK)
06/03/202416h06Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:AZNCFAstraZeneca Plc (PK)
06/03/202413h21Edgar (US Regulatory)Form CERT - Certification by an exchange approving securities for listingUSOTC:AZNCFAstraZeneca Plc (PK)
05/03/202422h40Edgar (US Regulatory)Form 8-A12B - Registration of securities [Section 12(b)]USOTC:AZNCFAstraZeneca Plc (PK)
04/03/202412h33Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:AZNCFAstraZeneca Plc (PK)
01/03/202416h39Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:AZNCFAstraZeneca Plc (PK)
22/02/202412h08Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:AZNCFAstraZeneca Plc (PK)
21/02/202414h32Edgar (US Regulatory)Form SC TO-T/A - Tender offer statement by Third Party: [Amend]USOTC:AZNCFAstraZeneca Plc (PK)
21/02/202414h13Edgar (US Regulatory)Form 424B2 - Prospectus [Rule 424(b)(2)]USOTC:AZNCFAstraZeneca Plc (PK)
21/02/202412h04Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:AZNCFAstraZeneca Plc (PK)
20/02/202423h19Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansUSOTC:AZNCFAstraZeneca Plc (PK)
20/02/202422h34Edgar (US Regulatory)Form IRANNOTICE - Notice of disclosure filed pursuant to Section 219 of the Iran Threat Reduction and Syria Human Rights Act of 2012 (Exchange Act Section 13(r)).USOTC:AZNCFAstraZeneca Plc (PK)
20/02/202422h22Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:AZNCFAstraZeneca Plc (PK)
20/02/202415h25Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:AZNCFAstraZeneca Plc (PK)
20/02/202413h51Edgar (US Regulatory)Form SC TO-T/A - Tender offer statement by Third Party: [Amend]USOTC:AZNCFAstraZeneca Plc (PK)
20/02/202413h49Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:AZNCFAstraZeneca Plc (PK)
20/02/202413h12Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:AZNCFAstraZeneca Plc (PK)
20/02/202412h52Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:AZNCFAstraZeneca Plc (PK)
20/02/202412h47Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:AZNCFAstraZeneca Plc (PK)
20/02/202412h27Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:AZNCFAstraZeneca Plc (PK)
12/02/202416h13Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]USOTC:AZNCFAstraZeneca Plc (PK)
08/02/202412h40Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:AZNCFAstraZeneca Plc (PK)
01/02/202416h30Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:AZNCFAstraZeneca Plc (PK)
 Showing the most relevant articles for your search:USOTC:AZNCF

Kürzlich von Ihnen besucht

NASDAQ
LFMD
LifeMD
LSE
SDUE
Ish Eu Esg G-d
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten